We examined the effects of lactic acid fermentation of soymilk on the lipid profile and lipid metabolism-related gene expression in rat liver. Male Sprague-Dawley rats aged 7 weeks were fed a control diet (AIN-93), soymilk diet, or fermented soymilk diet for 1 week or 5 weeks. The hepatic triglyceride and cholesterol contents in the soymilk (SM) group and the fermented soymilk (FSM) group were significantly lower than those in the control group after 5 weeks, but these changes had not become apparent until after 1 week. The fatty acid synthesisrelated genes were more markedly down-regulated after 1 week than after 5 weeks, whereas the cytochrome p450 family 7 subfamily a polypeptide 1 (CYP7al) gene related to cholesterol catabolism was more markedly up-regulated after 5 weeks than after 1 week. This upregulation was higher in the FSM group than in the SM group. It is assumed that the bioactive components produced by lactic acid fermentation induced the upregulation of CYP7a1.
It is well known that soy foods contain abundant protein; soymilk, tofu, soy sauce, miso and natto particularly are traditional soy products in Japan. The physiological effects of soy foods have been elucidated by many animal and clinical studies. The major bioactive ingredients of soy are considered to be soy protein and isoflavone. Soy protein has reduced the cholesterol and triglyceride concentrations in the plasma and liver. 1, 2) Furthermore, isoflavones have weak estrogenic activity 3) and reduce the risk of cardiovascular disease. Genistein and daizein modulate the hepatic glucose and lipid-regulating enzyme activities. 4, 5) Two meta-analyses have reported that the intake of soy protein and isoflavone reduced the levels of serum total cholesterol, LDL-cholesterol and triglycerides, and increased that of HDL-cholesterol. 6, 7) The recently increasing use of soy food in diets has thus aroused a surge of interest in the potential physiological benefits. [8] [9] [10] Soymilk contains abundant soy protein and isoflavone, and the intake of soymilk has reduced the plasma and hepatic lipid levels. 11, 12) We focused on the positive use of soymilk, because it is easy to incorporate in a diet. We prepared soymilk fermented with lactic acid bacteria of vegetable origin in order to ingest it more easily. We have previously reported that fermented soymilk reduced the plasma and hepatic cholesterol concentrations in rats fed on a high-cholesterol diet 13) and that more than a 10% of soy protein in the diet was necessary to achieve a significant physiological effect on rats fed with a cholesterol-free diet by ingesting fermented soymilk. 14) Fermented soymilk prepared by using bifidobavterium breve YIT 4065 has been reported to improve the lipid metabolism. 12, 15) We investigated in our previous study 16) the effects of lactic acid-fermented soymilk containing okara on the plasma and hepatic lipid profiles and expression of the lipid metabolism-related genes in rats. However, the mechanism involved in the lactic fermentation of soymilk for the lipid metabolism-related gene expression in rat liver has not yet been elucidated. Furthermore, the effect of the administration period for fermented soymilk on lipid metabolism-related gene expression is not clearly understood.
The different effects between soymilk and fermented soymilk on lipid metabolism and lipid metabolismrelated gene expression were therefore investigated to clarify the regulation of hepatic gene expression incurred by lactic acid-fermented soymilk. Short-term feeding for 1 week and long-term feeding for 5 weeks were also examined to confirm the effect of administration period.
Materials and Methods
Diets. The fermented soymilk was prepared by lactic acid fermentation by the Lactobacillus delbrueckii subsp. delbrueckii strain of SNC33 for 15 h and then immediately freeze-dried for the animal y To whom correspondence should be addressed. Fax: +81-798-45-9879; E-mail: maki1002@mukogawa-u.ac.jp Abbreviations: ACAT, acetyl-CoA acetyltransferase; ACC, acetyl-CoA carboxylase; CPT-1, carnitine palmitoyltransferase 1; CYP7a1, cytochrome p450 family 7 subfamily a polypeptide 1; FAS, fatty acid synthase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase; LDLR, low-density lipoprotein receptor; LXR, liver X receptor alpha; PPAR, peroxisome proliferator activated receptor alpha; SREBP-1, sterol regulatory element binding protein 1; SREBP-2, sterol regulatory element binding protein 2; SM, soymilk; FSM, fermented soymilk experiments. Plain soymilk was also freeze-dried for the animal experiments. The compositions of soymilk and fermented soymilk are shown in Table 1 . The other feed materials were purchased from Clea Japan (Tokyo, Japan) and Wako Pure Chemical Industries (Osaka, Japan).
Animals. Forty eight male Sprague-Dawley rats (7 weeks old) were purchased from Nihon SLC (Hamamatsu, Japan) and individually housed in cages at a temperature of 23 AE 1 C and a humidity of 55 AE 7% with a 12-h light-dark cycle. All the rats were acclimatized on an AIN-93G diet for 1 week to stabilize the metabolic conditions before the feeding experiments.
Experiment 1: feeding for 5 weeks. Twenty four rats were assigned to three groups (n ¼ 8) which did not exhibit any significant difference in the body weight and serum total cholesterol concentration from each other. The control (CO) group was fed with the AIN-93G diet. The soymilk (SM) group was fed with a diet in which 23.2% of the control diet had been replaced with dried soymilk so that 10% soy protein was contained as the final concentration, and the fermented soymilk (FSM) group was fed with a diet in which 24.1% of the control diet had been replaced with dried fermented soymilk so that 10% soy protein was contained as the final concentration ( Table 2 ). The rats in each group were fed the appropriate diet for 5 weeks and provided with ad libitum access to the diet and water. The food intake was recorded daily, and the body weight was measured on alternate days. All the rats were fasted for 8 h (8:00-16:00) on one day of each week during the feeding period, and blood was withdrawn from the tail vein under anesthesia with diethyl ether. The plasma immediately obtained by centrifugation was stored at À80 C until needed. The non-fasted rats were sacrificed after the feeding period without any affliction from the diethyl ether anesthetic, and the liver was quickly removed and washed with ice-cold physiological saline. After the weight of the tissues had been measured, the liver tissues were immediately immersed in RNA Later (Qiagen, Tokyo, Japan) and kept at À80 C until needed.
Experiment 2: feeding for 1 week. Twenty four rats were assigned to three groups (n ¼ 8) which did not exhibit any significant difference in the body weight and serum total cholesterol concentration from each other. Feeding the diets was the same as described for experiment 1. The non-fasted rats were sacrificed after the feeding period without any affliction by diethyl ether anesthesia, and the liver tissues were treated by same method as that described in experiment 1.
These animal experiments were performed according to the guidelines from the Animal Use Committee of Mukogawa Women's University.
Measurement of the plasma and liver metabolic parameters. Plasma total cholesterol (TC), HDL-cholesterol (HDL-C), and triglyceride (TG) were enzymatically measured by using commercial kits (Cholesterol E-test, HDL-cholesterol E-test, and Triglyceride E-test; Wako Pure Chemical Industries). The non-HDL-C concentration was calculated as [non-
The hepatic lipids were extracted by the method of Folch et al., 17) the hepatic cholesterol and TG concentrations being enzymatically determined as already described.
RNA extraction. Total RNA was extracted from the liver tissues with the RNeasy Mini kit (Qiagen, Tokyo, Japan). The quality and quantity of isolated total RNA were checked by agarose gel electrophoresis and spectrophotometry. Equal amounts of isolated total RNA from eight rats in each group were mixed and used in the DNA microarray analysis.
DNA microarray analysis. Six RNA samples (10 mg each) were analyzed by the MAMR-01 GeneSQUARE Ò multiple assay DNA microarray metabolic syndrome gene expression kit for rats (Kurabo Industries, Osaka, Japan). Alexa Fluor Ò 555-labeled cDNA was prepared from hepatic total RNA by cDNA synthesis, and in vitro transcription was performed by the MADL-1 GeneSQUARE Ò cDNA direct labeling system (Kurabo Industries) according to the manufacturer's protocol. Labeled cDNA was purified with a MinElute PCR purification kit (Qiagen, Hilden, Germany) and added to a hybridization buffer (5Â SSC at pH 7.0, 4Â Denhardt's solution (SigmaAldrich, St. Louis, MO, USA), 1 mg of salmon sperm DNA (Invitrogen, Carlsbad, CA, USA) and 0.5% (w/v) SDS. Hybridization was performed in a final volume of 8 mL per well by the GeneSQUARE Ò multiple assay DNA microarray metabolic syndrome gene expression kit for rats (Kurabo Industries Ltd.) in a an MAHC hybridization chamber (Kurabo Industries Ltd.) at 65 C for 16 h. The hybridized slides were washed by the following steps after hybridization: (i) immersion in a 1Â SSC and 0.1% SDS solution for 5 min, (ii) immersion in a 0:2Â SSC and 0.1% SDS solution for 5 min, (iii) immersion in a 0:2Â SSC and 0.1% SDS solution at 55 C for 5 min, (iv) rocking in 0:2Â SSC, and (v) immersion in 0.05% SSC for 2 min. After being dried by centrifuge, the slides were scanned by GenePix 4000B with GenePix Pro 6.0.1.27 (Molecular Devices, Sunnyvale, CA, USA). The fluorescence intensity of each scanned image was quantified, and then normalized to the intensity of GAPDH.
Real-time reverse transcription-polymerase chain reaction (RT-PCR). The expression of mRNA was quantitatively measured by realtime RT-PCR, using the model 7500 (Applied Biosystems, Foster City, CA, USA) and related reagent kits according to the manufacturer's protocol. Total RNA was extracted from liver tissues with the RNeasy mini kit (Qiagen). The genomic DNA in total RNA was digested by Turbo DNase (Applied Biosystems). Complementary DNA (cDNA) was synthesized from the DNase-treated RNA by using a high capacity cDNA reverse transcription kit with an RNase inhibitor (Applied Biosystems). The following TaqMan Ò gene expression assays were conducted, using Rn01495769 ml for Srebf1 (mRNA of SREBP-1), Rn00569117 ml for Fasn (mRNA of FAS), Rn00573474 ml for Acaca (mRNA of ACC), Rn00581185 ml for Nr1h3 (mRNA of LXR), Rn01502638 ml for Srebf2 (mRNA of SREBP-2), Rn00565598 ml for Hmgcr (mRNA of HMGCR) and Rn00564065 ml for Cyp7a1 (Applied Biosystems) as the PCR primer sets for real-time PCR. Rn99999916 s1 for GAPDH was used as an endogenous control. Real-time PCR was performed with the TaqMan Ò Universal PCR master mix (Applied Biosystems). Data were normalized to GAPDH RNA expression, and the no.-fold is presented as a ratio to CO.
Isoflavones in the diet and plasma. Isoflavone was measured after extracting 0.25 g of the diet with 5 mL of 70% ethanol at room temperature for 24 h and then centrifuging at 10;000 Â g for 30 min at room temperature. The supernatant was collected and filtered through a cellulose acetate membrane (Tosoh, Japan). Isoflavones in the SM and FSM diets were analyzed by HPLC (Tosoh, Japan) equipped with an ODS-80Ts column, using gradient elution by acetonitrile from 15% to 35% in 0.1% acetic acid. Isoflavones in the plasma were analyzed by HPLC, using gradient elution by a solvent of sodium acetate (pH 4. 
Results
Body weight, food intake, food efficiency and tissue weights No significant differences in the final body weight, food intake and food efficiency were found among the three groups in either experiment 1 (short-term administration) or 2 (long-term administration) ( Table 3 ). The liver weights of the SM and FSM groups after 5 weeks were significantly lower than that of the CO group, but there was no significant difference among the three groups after 1 week (Table 3) . These results indicate that the long-term administration of soymilk and fermented soymilk obviously affected the lipid metabolism and decreased the liver weight.
Plasma lipid level
The plasma TC levels of the SM and FSM groups were significantly lower than that of the CO group from 1 week to 5 weeks (Table 4) . Although the ingestion of SM and FSM did not affect plasma non-HDL-C for the first 3 weeks, non-HDL-C of the SM and FSM groups was temporarily lower than that of the CO group in the 4th week. The ratio of HDL-C/TC in the SM and FSM groups also temporarily increased in the 4th week. On the other hand, the plasma TG level of the SM and FSM groups tended to decrease.
Hepatic lipid level
Although the hepatic TG and cholesterol contents were not affected in comparison with the CO group after 1 week, the levels were significantly lower in the SM and FSM groups after 5 weeks as shown in Table 5 . These data suggest that the long-term administration of SM and FSM affected the fatty acid and cholesterol metabolism. No difference in the hepatic lipid profile was found between the SM and FSM groups.
DNA microarray analysis
The ingestion of SM or FSM decreased the lipid levels in the plasma and liver, so the change of lipid metabolism-related gene expression in the rat liver was cyclopaedically investigated by using a DNA microarray analysis. The effects on gene expression of the administration period for 1 week and 5 weeks were also compared. The lipid metabolism-related genes whose expression levels in the SM and FSM groups vs. the CO group differed by more than 1.5-fold or less than 0.7-fold are respectively shown as being up-regulated and down-regulated. Administering the diet for 1 week (experiment 2) respectively suppressed the gene expression ratio of SREBP-1 in the SM and FSM groups to 0.7 and 0.8 ( Table 6 ). The expression ratio of FAS was also obviously down-regulated to 0.5 in both the SM and FSM groups. The expression ratio of ACC was also suppressed in both the SM and FSM groups to 0.8. These data suggest that the ingestion of SM and FSM down-regulated the fatty acid synthesis-related genes after 1 week, although the fatty acid catabolism-related gene, PPAR, was not affected. However, the CPT-1 genes in the SM and FSM groups were respectively decreased to ratios of 0.7 and 0.8. The expression ratio of CYP7a1, cholesterol catabolism-related gene, in the SM group was obviously decreased to 0.7 after administering the diet for 1 week, whereas the ratio of this gene in the FSM group was increased to 1.6 ( Table 7 ). The effect on gene expression was different in experiment 1 with diet administration for 5 weeks (Table 6 ). The suppression ratio of FAS in both the SM and FSM groups was maintained at 0.7, while the SREBP-1 gene expression ratio was scarcely suppressed in the SM and FSM groups (at 0.8 and 0.9, respectively). The expression ratio of ACC was virtually unaffected in the SM and FSM groups (at 1.2 and 1.1, respectively) . The, fatty acid catabolism-related genes were also scarcely affected, and the CPT-1 gene expression ratios in SM and FSM groups were respectively suppressed at 0.8 and 0.7. The expression of the cholesterol metabolism-related genes was affected by the ingestion of SM and FSM: the expression ratio for CYP7a1 in the SM group was up-regulated to 1.6, and that of FSM group was up-regulated to 3.1 (Table 7) , while the ratio for the ACAT2 gene in the SM and FSM groups was also respectively up-regulated to 1.6 and 1.7.
Real-time PCR analysis
The DNA microarray results show that the ingestion of SM and FSM affected the fatty acid synthesis-related genes and cholesterol metabolism-related genes. A realtime (RT)-PCR analysis was therefore carried out on the important of these genes and other important genes to confirm the hepatic gene expression by using a DNA microarray analysis. SM and FSM scarcely downregulated SREBP-1 gene expression after feeding for 1 week in experiment 2 (Fig. 1) . The gene expression of FAS was significantly lower in the SM group (p < 0:05) and FSM group (p < 0:01) vs. the CO group after 1 week, whereas the ACC gene expression was scarcely affected. These data indicate that the ingestion of SM and FSM down-regulated the fatty acid synthesisrelated gene after 1 week, but that SM and FSM scarcely down-regulated FAS and did not affect the downregulation of ACC after feeding for 5 weeks in experiment 1 (Fig. 1) .
The SM and FSM groups did not significantly change the expression of the cholesterol metabolism-related genes, except for LXR after 1 week of feeding in experiment 2 (Fig 2) . However, after 5 weeks of feeding Data were normalized to GAPDH and are presented as a ratio to the CO group; means of more than 1.5 or less than 0.7 are respectively shown as upregulated and down-regulated. Data were normalized to GAPDH and are presented as a ratio to the CO group; means more than 1.5 or less than 0.7 are respectively shown as upregulated and down-regulated. The data were normalized to GAPDH RNA expression and are presented as a ratio to the CO value. Each value is the mean AE SE for 8 rats.
Ratio to CO (vs
a,b Means not sharing a common superscript differed significantly by Tukey's multiple-comparison test (p < 0:05).
in experiment 1, the gene expression of LXR was significantly higher in the SM group (p < 0:05) and FSM group (p < 0:05) than in the CO group. In particular, the gene expression of Cyp7a1 in the FSM group was significantly up-regulated (p < 0:001) compared with that in the CO group and (p < 0:05) compared with that in the SM group. The gene expression of SREBP-2 was also significantly higher in the SM group (p < 0:01) and FSM group (p < 0:001) compared with that in the CO group. However, higher HMGCR gene expression was not apparent.
Isoflavones in the diet and plasma
The glucoside and aglycone of the major isoflavones in SM and FSM are shown in Table 8 . The fermented soymilk contained a higher amount of the isoflavone aglycone, daidzein and genistein than soymilk. Plasma isoflavones contained equally in the SM and FSM groups were greater than in the CO group. Although the amount of plasma isoflavones in the FSM group was higher than that in the SM group, the difference was not significant (data are not shown).
Discussion
The effects of SM and FSM on lipid metabolism in the plasma and liver of rats were investigated in the present study. After feeding for 5 weeks, the SM and FSM groups had significantly decreased plasma TC and hepatic lipid levels, although the plasma TG level was not affected (Tables 4 and 5 ). No significant difference in plasma lipid profile between the SM and FSM groups was apparent.
The liver weights in the SM and FSM groups also decreased after 5 weeks (Table 3 ). The SM and FSM groups were inclined to show a respective decreased ratio for visceral fat, subcutaneous fat and total fat mass of 0.9, 0.9 and 0.9 (data are not shown). Although the SM and FSM groups showed a significantly decreased plasma TC level by feeding for 1 week, the plasma TG and hepatic lipid levels were not affected (Tables 4 and  5 ). These results indicate that feeding for 1 week was too short to induce the effects of soymilk and fermented soymilk on the lipid profile in the plasma and liver.
The gene expression of FAS was obviously decreased in the SM and FSM groups after 1 week, although the expression of FAS was scarcely changed after 5 weeks. It has been reported that the gene expression of SREBP-1 and FAS was controlled by LXR. 18) Although the gene expression of LXR was up-regulated in the SM and FSM groups, the target genes, SREBP-1 and FAS, were not up-regulated. It seems that a gene other than LXR controlled the SREBP-1 and FAS gene expression. The hepatic TG level was significantly decreased in the SM and FSM groups after 5 week. However, no rapid decrease of hepatic TG was apparent after 1 week. These data suggest that the change in hepatic TG level by ingesting SM and FSM lagged behind the downregulation of gene expression, because the effect of FAS down-regulation was attenuated by the longer administration of SM and FSM.
CYP7a1, the rate-limiting enzyme for cholesterol metabolism in the formation of bile acid from cholesterol, 19) is controlled by LXR. 20) The gene expression of LXR was obviously up-regulated in the SM and FSM groups after 5 weeks. It also seems that soy protein and isoflavone increased the CYP7al activity. 21, 22) Although the expression of CYP7a1 in the SM and FSM groups was not significantly affected after 1 week (Fig. 2) , the respective CYP7a1 ratio in the SM and FSM groups was significantly up-regulated after 5 weeks to 1.8 (p < 0:05) and 2.5 (p < 0:001). CYP7a1 gene expression was therefore significantly more upregulated in the FSM group (p < 0:05) than in the SM group. It seems that lowering the plasma TC level depended on the acceleration of cholesterol catabolism by up-regulating the hepatic CYP7a1 gene, 23 ) although the change in TC level at the early stage of SM and FSM feeding appears not to have been related to the upregulation of CYP7a1. It seems that the up-regulation of CYP7a1 was mediated by the signal transfer of LXR in the SM and FSM groups after 5 weeks. In addition, the gene for SREBP-2 controlled by LXR 24) was upregulated in the SM and FSM groups after 5 weeks (Fig. 2) . It has been reported that CYP7a1 gene expression was not mediated by SREBP2, 25) and that soy protein stimulated CYP7a1 expression 26) for the catabolism to bile acid from cholesterol.
27) The upregulation of SREBP-2 accelerating cholesterol synthesis in the present study seems to have compensated for the loss of hepatic cholesterol induced by upregulation of the CYP7a1 gene. On the other hand, the gene expression of HMGCR, the rate-limiting enzyme in cholesterol synthesis, 28, 29) was scarcely increased in the SM and FSM groups after 5 weeks. The data were normalized to GAPDH RNA expression and are presented as a ratio to the CO value. Each value is the mean AE SE for 8 rats.
a,b,c Means not sharing a common superscript differed significantly by Tukey's multiple-comparison test (p < 0:05).
It has been reported that isoflavone derived from Kudzu roots had hypocholesterolemic activity mediated by increased CYP7a1 gene expression. 30) Furthermore, a soy protein isolate (SPI), after removing isoflavone by ethanol washing, exhibited lower CYP7a1 gene expression than untreated SPI. 31) Isoflavone-poor soy protein similarly reduced CYP7a1 gene expression. 32) Isoflavone therefore seems to have been important in the gene expression of CYP7a1. To enhance the bioavailability of isoflavone, it is necessary for the isoflavone glucoside to be converted to the aglycone, the form most easily absorbed in intestines, by intestinal microbial -glucosidase. It has been reported that the isoflavone glucoside in soymilk was converted to the aglycone by fermentation with lactic acid bacteria. 33) We examined in the present study the isoflavone components in each diet. The fermented soymilk contained a higher level of the isoflavone aglycone, daidzein and genistein, than the soymilk ( Table 8 ). The rapid up-regulation of CYP7a1 might therefore have been due to conversion of the isoflavone glucoside to the aglycone whose absorption in intestine was stimulated. 34) On the other hand, it has been reported that the oligopeptide derived from bovine milk -lactoglobulin, lactostatin, decreased the plasma TC level mediated by an increased CYP7a1 gene expression. 35) It is likely that soy peptides would exhibit a hypocholesteromic effect if lactic acid fermentation could convert soy protein to bioactive peptides. 36) However, the proteins in fermented soymilk were found to be scarcely digested by comparing the HPLC patterns of unfermented and fermented soymilk proteins.
Although the administration of SM and FSM in the present study for 1 week was too short to induce an effect on the lipid profile in the plasma and liver, it appears that the gene expression for fatty acid synthesis was more markedly down-regulated after 1 week than after 5 weeks in the SM and FSM groups. On the contrary, the cholesterol metabolism-related gene expression was more markedly up-regulated after 5 weeks than after 1 week in the SM and FSM groups. It seems that the administration time required for gene expression was different between fatty acid metabolism and cholesterol metabolism. It is assumed that the bioactive components produced by lactic acid fermentation, isoflavones and others, induced the up-regulation of hepatic CYP7al to reduce the plasma cholesterol level in rats.
